for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Raia Drogasil SA

RADL3.SA

Latest Trade

103.63BRL

Change

2.18(+2.15%)

Volume

1,282,900

Today's Range

101.30

 - 

103.95

52 Week Range

55.26

 - 

104.04

As of on the Bolsa de Valores do Estado de Sao Paulo ∙ Minimum 15 minute delay

Pricing

Previous Close
101.45
Open
101.86
Volume
1,282,900
3M AVG Volume
27.64
Today's High
103.95
Today's Low
101.30
52 Week High
104.04
52 Week Low
55.26
Shares Out (MIL)
329.64
Market Cap (MIL)
33,990.11
Forward P/E
64.42
Dividend (Yield %)
0.55

Next Event

Q3 2019 Raia Drogasil SA Earnings Release

Latest Developments

More

Raia Drogasil SA announces own capital interest payment

Raia Drogasil SA reviews store opening guidance

Raia Drogasil SA completes acquisition of majority stake in 4-Bio Medicamentos SA

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Raia Drogasil SA

Raia Drogasil SA is a Brazil-based company engaged in retail sales of medications, specialty medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The Company’s sales are carried out by over 860 stores, located in the states of Sao Paulo, Minas Gerais, Rio de Janeiro, Parana, Goias, Espirito Santo, Santa Catarina, Rio Grande do Sul, Bahia, Mato Grosso and Mato Grosso do Sul and in the Distrito Federal. The Company operates through a range of subsidiaries, such as Raia SA and 4-Bio Medicamentos SA.

Industry

Retail (Drugs)

Contact Info

Av. Corifeu de Azevedo Marques

3097., Butanta

+55.11.37695678

https://www.rd.com.br

Executive Leadership

Antonio Carlos Pipponzi

Chairman of the Board

Marcilio D'Amico Pousada

Chief Executive Officer, Member of the Executive Board

Antonio Carlos Coelho

Chief Financial Officer, Member of the Executive Board

Fernando Kozel Varela

Chief of Technology, Supply Chain and Omnichannel

Marcello de Zagottis

Chief Marketing, Sales and Commercial Officer, Member of the Executive Board

Key Stats

3.11 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, BRL)

2016

11.3K

2017

13.2K

2018

14.8K

2019(E)

17.2K
EPS (BRL)

2016

1.515

2017

1.549

2018

1.520

2019(E)

1.597
Price To Earnings (TTM)
71.84
Price To Sales (TTM)
2.13
Price To Book (MRQ)
9.55
Price To Cash Flow (TTM)
27.88
Total Debt To Equity (MRQ)
130.97
LT Debt To Equity (MRQ)
106.99
Return on Investment (TTM)
8.06
Return on Equity (TTM)
5.39

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up